KZKrzysztof Zeman

Krzysztof Zeman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Krzysztof Zeman has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dental Health Assessment in Pediatric Patients with 22q11.2 Deletion Syndrome

    by Marta Łyszczarz, Agnieszka Moll-Maryńczak, Sylwia Majewska-Beśka, Krzysztof Zeman, Marcin Tkaczyk

    The aims of this study were to provide a comprehensive evaluation of the dental status in pediatric patients with 22q11.2 deletion syndrome (22q11.2DS) and to analyze the associations between clinical dental findings, general medical conditions, and oral hygiene habits. The cross-sectional study included 20 children (10 girls, mean age 6.45 years) with a confirmed diagnosis of 22q11.2DS. Each child underwent a detailed dental examination, including caries (dmft/DMFT: decayed, missing, and filled teeth index for primary and permanent teeth), developmental defects of enamel (DDE), hypodontia, occlusal relationship disorder, and soft tissue findings assessment. Additionally, the functioning of the oral cavity, especially speech and swallowing patterns, was evaluated. Dental findings were correlated with medical history, oral hygiene habits, and laboratory results, with a specific focus on calcium-phosphate metabolism and immunological parameters. Categorical variables were reported as counts and percentages, while continuous variables were presented as medians and interquartile ranges. Nonparametric methods, including Fisher's exact test and the Mann–Whitney U test, were used for group comparisons. Correlations were assessed using Pearson's (r) and Spearman's rank correlation coefficients. All tests were two-tailed with a significance level of α = 0.05. DDE were identified in 13 (65%) children, of whom 6 (30%) were presented with only hypomineralization, 4 (20%) exhibited only hypoplasia, and 3 (15%) demonstrated both defects. Caries prevalence was 70%, with a mean dmft of 4.65 (standard deviation [SD] 5.05) and DMFT of 8.6 (SD 5.77). Occlusal relationship disorders were observed in 11 (55%) children and hypodontia in 3 (15%) children. Age was the most significant variable associated with caries experience (r = 0.73, p < 0.001), while dysmorphic features were the only significant factor for DDE (p = 0.022). No significant correlations were found between dental findings and laboratory parameters or oral hygiene habits. The most common dental manifestations of 22q11.2DS are DDE, dental caries, and oral dysfunctions. No direct correlation was found between oral health and immunological status or calcium-phosphorus metabolism. Caries is a significant problem and more dependent on age than on oral hygiene alone. Patients require early, comprehensive, and coordinated care from dentists, orthodontists, and speech-language pathologists.

  • Open Access

    Severe neurological and ocular manifestations in paediatric patients with toxoplasmosis. Case-series study with review of the current literature

    by Katarzyna Mikołajczyk, Agata Joanna Ordon, Anna Kuc, Ewa Majda-Stanisławska, Krzysztof Zeman, Marcin Tkaczyk

    Toxoplasmosis, both congenital and postnatally acquired, is a parasitic disease caused by infection with the protozoan Toxoplasma gondii. The most serious manifestation of this disease is congenital toxoplasmosis, resulting from transplacental infection of the foetus during pregnancy. Retinochoroiditis, intracranial calcifications, and hydrocephalus are considered the classic triad of congenital toxoplasmosis. This article describes four cases of severe neurologic and ocular manifestations in paediatric patients diagnosed with toxoplasmosis. The main aim was to examine the nature of clinical presentation as well as to emphasise the necessity of properly administered antiparasitic therapy and underline the importance of prenatal screening to reduce the risk of congenital transmission to the foetus.


  • Clinical immunology in Poland: achievements and challenges – status as for 2024

    by Sylwia Kołtan, Jarosław Baran, Katarzyna Bąbol-Pokora, Rafał Becht, Elżbieta Berdej-Szczot, Ewa Bernatowska, Katarzyna Bogunia-Kubik, Lidia Gackowska, Elżbieta Grześk, Edyta Heropolitańska-Pliszka, et al.

    The dynamic development of clinical immunology in Europe began in mid 1980s, and was continued in Poland shortly thereafter. In 1993 the first national consultant in the field of clinical immunology was appointed in Poland. A milestone was the establishment of the Polish Working Group for Primary Immunodeficiencies (PGR for PID) in 2005. Since then, a network of numerous paediatric and internal medicine centres has been created within the Group, facing and resolving new challenges in the field. The study presents the organization of care for patients with primary and secondary immunodeficiencies in Poland, analyzes the staffing situation and patients' access to diagnostics and treatment between late 1980’s and 2024. The summary presents the achievements resulting in improved diagnostic efficiency, shortening the delay in the diagnosis of Inborn Errors of Immunity (IEI)/primary immunodeficiencies (PID), and better access of patients to therapy within drug programs, largely carried out at home. The causes hindering the development of specialization are also analyzed. The most important among them are the lack of systemic support on the part of medical care organizers and the lack of motivation of young doctors to pursue specialization. The main goal is to improve diagnostic and therapeutic procedures for PID patients, including newborn screening, highly specialized, genetic test regardless where they are implemented. It can be only achieved with their better financing. An essential problem is the lack of an epidemiological or clinical IEI registry.


  • Open Access

    Analiza wielokierunkowa czynników towarzyszących nadwadze i otyłości u dzieci i młodzieży – badanie przekrojowe

    by Aneta Gwozdowska, Kinga Polańska, Ewa Starostecka, Krzysztof Zeman, Kamil Gwozdowski, Dorota Kaleta, Leokadia Bąk-Romaniszyn

    Introduction and objective: Overweight and obesity in children and adolescents has been one of the major health and social challenges worldwide for several decades. Obesity is a multifactorial disease in which the risk factors may appear with various severity and combinations. The aim of the...

  • Open Access

    Biochemical and cardiovascular predictors of PIMS risk in children after COVID-19 recovery =- the results of the LATE COVID Kids study

    by I Jatczak-Pawlik, J Lewek, E Czkwianianc, K Zeman, P Jankowski, M Banach, the LATE-COVID-Kids study.

    Background: Unfortunately, the number of children with the pediatric inflammatory multisystem syndrome (PIMS) associated with previous coronavirus disease has been increasing significantly. Purpose: The aim of the present study was to characterize biochemical and cardiovascular predictors of PIMS risk in children recovered from COVID-19 based on the data from the LATE-COVID-Kids study (NCT04799444). Methods: 131 consecutive COVID-19 convalescents (mean age: 8.89±4.91; 67 boys and 64 girls) hospitalized for the clinical evaluation after the acute phase of the COVID-19 were classified into two groups related to symptoms: 29 children finally diagnosed with PIMS and 102 children with no-PIMS. All patients had confirmed coronavirus infection based on the positive results of nucleic acid test (RT-PCR - reverse transcriptase-polymerase chain), and they were serologically tested for antibodies against SARS-CoV-2. They had detailed laboratory testing, electrocardiography, and echocardiography. Results: The time from COVID-19 recovery was from 1 to 10 months (median 4.0 [3.00–5.00] months). Children with PIMS were significantly younger in comparison to those without (6.60±4.50 vs 9.50±4.80 years, respectively; p=0,005). In comparison to non-PIMS group, children with PIMS had higher level of antithrombin III (111±7.23 vs. 104±10.9; p=0.0015), CK-MB (29.0 [18.5–36.0] vs. 21.0 [15.0–30.7]; p=0.03) and heart rate [HR]/min (100 [89.0–112] vs. 90.0 [79.0–100]; p=0.006) but lower PQ interval (120 [110–120] vs. 130 [120–140]; p=0.023) on admission to hospital. Moreover, the immunological parameters: IgA and neutrophils were lower in children with PIMS vs. no-PIMS (0.69 [0.47–0.85] vs. 1.19 [0.71–1.50]; p=0.0001 and 37.4%±13.3 vs. 43.0±11.6; p=0.0045, respectively), but lymphocytes were significantly higher (50.6±13.6 vs. 43.7±10.9; p=0.002). Some acid-base balance parameters were higher in children following PIMS vs. no-PIMS children group: pCO2 (41.30±5.70 vs. 45.0±7.00; p=0.019), pO2 (50.1 [38.4–59.7] vs. 37.8 [27.9–49.9]; p=0.007), and O2Sat (84.2 [69.3–90.6] vs. 64.2 [44.3–82.6]; p=0.004); however, concentration of HCO3- (23.6 [22.2–24.4] vs. 24.3 [22.8–26.2]; p=0.023) was lower in group of PIMS children. Conclusions: Based on our best knowledge, it is the first data on the possible predictors of PIMS risk in children recovered from COVID-19. We showed that children with PIMS have significantly higher levels of antithrombin III, CK-MB, HR, as well as lymphocytes, pCO2, pO2 and O2Sat on admission to hospital and lower levels of PQ interval, IgA, neutrophils and concentration of HCO3. We continue our research to confirm these results and to create the PIMS SCORE algorithm to allow prediction of children with the risk of PIMS occurrence after COVID-19 recovery. Funding Acknowledgement: Type of funding sources: None.

  • Mannan-binding lectin deficiency in pediatric patients with inflammatory bowel disease

    by Leokadia Bak-Romaniszyn, Agnieszka Szala, Anna Sokolowska, Grazyna Mierzwa, Mieczyslawa Czerwionka-Szaflarska, Anna St. Swierzko, Krzysztof Zeman, Maciej Cedzynski

    Objective. The incidence of inflammatory bowel disease (IBD) in Europe has increased significantly. At least a fourth of patients are children. Mannan-binding lectin (MBL) is believed to be an important component of innate immunity, acting as an opsonin and activator of the lectin pathway (LP) of complement. The data relating any of the LP factors to IBD are sparse and contradictory and were obtained mainly from adult patients. The aim of this study was to investigate the possible role of MBL in Crohn's disease (CD) and ulcerative colitis (UC) in children. Methods. MBL2 gene single nucleotide polymorphisms (PCR-RFLP) and MBL concentrations (ELISA) were determined. Results. The frequency of MBL2 gene variants responsible for MBL deficiency (LXPA/O and O/O) is significantly higher in CD patients compared with controls or children with UC. A relatively high frequency of the codon 52 mutation (D allele) was noted in these patients. Practically no difference was found between UC and control (C) groups. Similarly, the average MBL levels as well as the number of MBL-deficient (MBL concentrations < 150 ng/ml) individuals differed between CD patients and controls or children suffering from UC. Again, there was no difference between UC and C groups. Conclusions. These data suggest that MBL deficiency may be associated with CD but not with UC in pediatric patients. The possible role of MBL in IBD requires confirmation in larger series and further investigation of the mechanisms involved.